{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:19:48Z","timestamp":1789978788391,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/nchembio.1889","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T15:32:09Z","timestamp":1439825529000},"page":"799-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["LAPTM4B facilitates late endosomal ceramide export to control cell death pathways"],"prefix":"10.1038","volume":"11","author":[{"given":"Tomas","family":"Blom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dichlberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"B\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Loizides-Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-9422","authenticated-orcid":false,"given":"Howard","family":"Riezman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Ikonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"BFnchembio1889_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.bbalip.2013.10.015","volume":"1841","author":"H Schulze","year":"2014","unstructured":"Schulze, H. & Sandhoff, K. Sphingolipids and lysosomal pathologies. Biochim. Biophys. Acta 1841, 799\u2013810 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio1889_CR2","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.febslet.2009.10.021","volume":"584","author":"T Kolter","year":"2010","unstructured":"Kolter, T. & Sandhoff, K. Lysosomal degradation of membrane lipids. FEBS Lett. 584, 1700\u20131712 (2010).","journal-title":"FEBS Lett."},{"key":"BFnchembio1889_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nm.1876","volume":"14","author":"E Lloyd-Evans","year":"2008","unstructured":"Lloyd-Evans, E. et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14, 1247\u20131255 (2008).","journal-title":"Nat. Med."},{"key":"BFnchembio1889_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1182\/blood-2013-03-488692","volume":"123","author":"AO Speak","year":"2014","unstructured":"Speak, A.O. et al. Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. Blood 123, 51\u201360 (2014).","journal-title":"Blood"},{"key":"BFnchembio1889_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/j.1600-0854.2012.01379.x","volume":"13","author":"T Blom","year":"2012","unstructured":"Blom, T., Li, Z., Bittman, R., Somerharju, P. & Ikonen, E. Tracking sphingosine metabolism and transport in sphingolipidoses: NPC1 deficiency as a test case. Traffic 13, 1234\u20131243 (2012).","journal-title":"Traffic"},{"key":"BFnchembio1889_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nature02188","volume":"426","author":"K Hanada","year":"2003","unstructured":"Hanada, K. et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426, 803\u2013809 (2003).","journal-title":"Nature"},{"key":"BFnchembio1889_CR7","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.bbalip.2013.12.013","volume":"1841","author":"J-P Truman","year":"2014","unstructured":"Truman, J.-P., Garc\u00eda-Barros, M., Obeid, L.M. & Hannun, Y.A. Evolving concepts in cancer therapy through targeting sphingolipid metabolism. Biochim. Biophys. Acta 1841, 1174\u20131188 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio1889_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","volume":"1841","author":"J-W Park","year":"2014","unstructured":"Park, J.-W., Park, W.-J. & Futerman, A.H. Ceramide synthases as potential targets for therapeutic intervention in human diseases. Biochim. Biophys. Acta 1841, 671\u2013681 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio1889_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.canlet.2011.07.010","volume":"332","author":"B Henry","year":"2013","unstructured":"Henry, B., M\u00f6ller, C., Dimanche-Boitrel, M.-T., Gulbins, E. & Becker, K.A. Targeting the ceramide system in cancer. Cancer Lett. 332, 286\u2013294 (2013).","journal-title":"Cancer Lett."},{"key":"BFnchembio1889_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrc1411","volume":"4","author":"B Ogretmen","year":"2004","unstructured":"Ogretmen, B. & Hannun, Y.A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4, 604\u2013616 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnchembio1889_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","volume":"13","author":"SAF Morad","year":"2013","unstructured":"Morad, S.A.F. & Cabot, M.C. Ceramide-orchestrated signalling in cancer cells. Nat. Rev. Cancer 13, 51\u201365 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnchembio1889_CR12","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/onc.2012.292","volume":"32","author":"T Kallunki","year":"2013","unstructured":"Kallunki, T., Olsen, O.D. & J\u00e4\u00e4ttel\u00e4, M. Cancer-associated lysosomal changes: friends or foes? Oncogene 32, 1995\u20132004 (2013).","journal-title":"Oncogene"},{"key":"BFnchembio1889_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature08710","volume":"463","author":"T Kirkegaard","year":"2010","unstructured":"Kirkegaard, T. et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 463, 549\u2013553 (2010).","journal-title":"Nature"},{"key":"BFnchembio1889_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","volume":"24","author":"NHT Petersen","year":"2013","unstructured":"Petersen, N.H.T. et al. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell 24, 379\u2013393 (2013).","journal-title":"Cancer Cell"},{"key":"BFnchembio1889_CR15","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1242\/jcs.091181","volume":"126","author":"S Aits","year":"2013","unstructured":"Aits, S. & J\u00e4\u00e4ttel\u00e4, M. Lysosomal cell death at a glance. J. Cell Sci. 126, 1905\u20131912 (2013).","journal-title":"J. Cell Sci."},{"key":"BFnchembio1889_CR16","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1158\/1535-7163.MCT-13-0084","volume":"12","author":"A-M Ellegaard","year":"2013","unstructured":"Ellegaard, A.-M. et al. Sunitinib and SU11652 inhibit acid sphingomyelinase, destabilize lysosomes, and inhibit multidrug resistance. Mol. Cancer Ther. 12, 2018\u20132030 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"BFnchembio1889_CR17","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","volume":"148","author":"JE Chipuk","year":"2012","unstructured":"Chipuk, J.E. et al. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148, 988\u20131000 (2012).","journal-title":"Cell"},{"key":"BFnchembio1889_CR18","first-page":"445","volume":"127","author":"FG Tafesse","year":"2014","unstructured":"Tafesse, F.G. et al. Sphingomyelin synthase-related protein SMSr is a suppressor of ceramide-induced mitochondrial apoptosis. J. Cell Sci. 127, 445\u2013454 (2014).","journal-title":"J. Cell Sci."},{"key":"BFnchembio1889_CR19","doi-asserted-by":"publisher","first-page":"e19783","DOI":"10.1371\/journal.pone.0019783","volume":"6","author":"H Lee","year":"2011","unstructured":"Lee, H. et al. Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PLoS ONE 6, e19783 (2011).","journal-title":"PLoS ONE"},{"key":"BFnchembio1889_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ccr.2007.04.011","volume":"11","author":"C Swanton","year":"2007","unstructured":"Swanton, C. et al. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell 11, 498\u2013512 (2007).","journal-title":"Cancer Cell"},{"key":"BFnchembio1889_CR21","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1158\/0008-5472.CAN-11-0940","volume":"71","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. Cancer Res. 71, 7481\u20137489 (2011).","journal-title":"Cancer Res."},{"key":"BFnchembio1889_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.canlet.2010.02.006","volume":"294","author":"H Yang","year":"2010","unstructured":"Yang, H. et al. Overexpression of LAPTM4B\u201335 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer Lett. 294, 236\u2013244 (2010).","journal-title":"Cancer Lett."},{"key":"BFnchembio1889_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nm.2090","volume":"16","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat. Med. 16, 214\u2013218 (2010).","journal-title":"Nat. Med."},{"key":"BFnchembio1889_CR24","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1038\/sj.onc.1206832","volume":"22","author":"G-Z Shao","year":"2003","unstructured":"Shao, G.-Z. et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene 22, 5060\u20135069 (2003).","journal-title":"Oncogene"},{"key":"BFnchembio1889_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10549-012-2340-x","volume":"137","author":"JJ De Ronde","year":"2013","unstructured":"De Ronde, J.J. et al. SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer Res. Treat. 137, 213\u2013223 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFnchembio1889_CR26","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.1074\/jbc.271.16.9801","volume":"271","author":"DL Hogue","year":"1996","unstructured":"Hogue, D.L., Ellison, M.J., Young, J.D. & Cass, C.E. Identification of a novel membrane transporter associated with intracellular membranes by phenotypic complementation in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 271, 9801\u20139808 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1889_CR27","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1074\/jbc.274.18.12877","volume":"274","author":"DL Hogue","year":"1999","unstructured":"Hogue, D.L., Kerby, L. & Ling, V. A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae. J. Biol. Chem. 274, 12877\u201312882 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1889_CR28","first-page":"4890","volume":"59","author":"MA Cabrita","year":"1999","unstructured":"Cabrita, M.A., Hobman, T.C., Hogue, D.L., King, K.M. & Cass, C.E. Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. Cancer Res. 59, 4890\u20134897 (1999).","journal-title":"Cancer Res."},{"key":"BFnchembio1889_CR29","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1038\/onc.2010.303","volume":"29","author":"L Li","year":"2010","unstructured":"Li, L. et al. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K\/AKT signaling. Oncogene 29, 5785\u20135795 (2010).","journal-title":"Oncogene"},{"key":"BFnchembio1889_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.15252\/embj.201489425","volume":"34","author":"X Tan","year":"2015","unstructured":"Tan, X. et al. LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation. EMBO J. 34, 475\u2013490 (2015).","journal-title":"EMBO J."},{"key":"BFnchembio1889_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cell.2014.12.006","volume":"160","author":"X Tan","year":"2015","unstructured":"Tan, X., Thapa, N., Sun, Y. & Anderson, R.A.A. Kinase-Independent Role for EGF Receptor in Autophagy Initiation. Cell 160, 145\u2013160 (2015).","journal-title":"Cell"},{"key":"BFnchembio1889_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1242\/jcs.076240","volume":"124","author":"S Vergarajauregui","year":"2011","unstructured":"Vergarajauregui, S., Martina, J.A. & Puertollano, R. LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV. J. Cell Sci. 124, 459\u2013468 (2011).","journal-title":"J. Cell Sci."},{"key":"BFnchembio1889_CR33","first-page":"3961","volume":"126","author":"V Pieti\u00e4inen","year":"2013","unstructured":"Pieti\u00e4inen, V. et al. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation. J. Cell Sci. 126, 3961\u20133971 (2013).","journal-title":"J. Cell Sci."},{"key":"BFnchembio1889_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/ncomms1735","volume":"3","author":"D Shen","year":"2012","unstructured":"Shen, D. et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat. Commun. 3, 731 (2012).","journal-title":"Nat. Commun."},{"key":"BFnchembio1889_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00418-009-0643-8","volume":"133","author":"CS Wegner","year":"2010","unstructured":"Wegner, C.S. et al. Ultrastructural characterization of giant endosomes induced by GTPase-deficient Rab5. Histochem. Cell Biol. 133, 41\u201355 (2010).","journal-title":"Histochem. Cell Biol."},{"key":"BFnchembio1889_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","volume":"206","author":"CP Reynolds","year":"2004","unstructured":"Reynolds, C.P., Maurer, B.J. & Kolesnick, R.N. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett. 206, 169\u2013180 (2004).","journal-title":"Cancer Lett."},{"key":"BFnchembio1889_CR37","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.1038\/onc.2010.379","volume":"29","author":"C Ji","year":"2010","unstructured":"Ji, C. et al. Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene 29, 6557\u20136568 (2010).","journal-title":"Oncogene"},{"key":"BFnchembio1889_CR38","doi-asserted-by":"publisher","first-page":"28200","DOI":"10.1074\/jbc.M110.216382","volume":"286","author":"C Bedia","year":"2011","unstructured":"Bedia, C., Casas, J., Andrieu-Abadie, N., Fabri\u00e0s, G. & Levade, T. Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine. J. Biol. Chem. 286, 28200\u201328209 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio1889_CR39","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1194\/jlr.M022384","volume":"53","author":"C Ullio","year":"2012","unstructured":"Ullio, C. et al. Sphingosine mediates TNF\u03b1-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells. J. Lipid Res. 53, 1134\u20131143 (2012).","journal-title":"J. Lipid Res."},{"key":"BFnchembio1889_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.cdd.4401382","volume":"11","author":"M Heinrich","year":"2004","unstructured":"Heinrich, M. et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 11, 550\u2013563 (2004).","journal-title":"Cell Death Differ."},{"key":"BFnchembio1889_CR41","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1093\/emboj\/18.19.5252","volume":"18","author":"M Heinrich","year":"1999","unstructured":"Heinrich, M. et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18, 5252\u20135263 (1999).","journal-title":"EMBO J."},{"key":"BFnchembio1889_CR42","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.1158\/0008-5472.CAN-05-0269","volume":"65","author":"MS Ostenfeld","year":"2005","unstructured":"Ostenfeld, M.S. et al. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res. 65, 8975\u20138983 (2005).","journal-title":"Cancer Res."},{"key":"BFnchembio1889_CR43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2183\/pjab.88.554","volume":"88","author":"K Sandhoff","year":"2012","unstructured":"Sandhoff, K. My journey into the world of sphingolipids and sphingolipidoses. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 88, 554\u2013582 (2012).","journal-title":"Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci."},{"key":"BFnchembio1889_CR44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244\u20131247 (2008).","journal-title":"Science"},{"key":"BFnchembio1889_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature10742","volume":"481","author":"F-X Contreras","year":"2012","unstructured":"Contreras, F.-X. et al. Molecular recognition of a single sphingolipid species by a protein\u2019s transmembrane domain. Nature 481, 525\u2013529 (2012).","journal-title":"Nature"},{"key":"BFnchembio1889_CR46","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.bbamem.2014.04.026","volume":"1838","author":"P Bj\u00f6rkholm","year":"2014","unstructured":"Bj\u00f6rkholm, P. et al. Identification of novel sphingolipid-binding motifs in mammalian membrane proteins. Biochim. Biophys. Acta 1838, 2066\u20132070 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio1889_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1470-2045(10)70018-8","volume":"11","author":"N Juul","year":"2010","unstructured":"Juul, N. et al. Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol. 11, 358\u2013365 (2010).","journal-title":"Lancet Oncol."},{"key":"BFnchembio1889_CR48","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/path.2998","volume":"226","author":"AJX Lee","year":"2012","unstructured":"Lee, A.J.X. et al. CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction. J. Pathol. 226, 482\u2013494 (2012).","journal-title":"J. Pathol."},{"key":"BFnchembio1889_CR49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bbrc.2009.01.106","volume":"380","author":"P Bandhuvula","year":"2009","unstructured":"Bandhuvula, P., Li, Z., Bittman, R. & Saba, J.D. Sphingosine 1-phosphate lyase enzyme assay using a BODIPY-labeled substrate. Biochem. Biophys. Res. Commun. 380, 366\u2013370 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnchembio1889_CR50","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1194\/jlr.M025692","volume":"53","author":"U Loizides-Mangold","year":"2012","unstructured":"Loizides-Mangold, U., David, F.P.A., Nesatyy, V.J., Kinoshita, T. & Riezman, H. Glycosylphosphatidylinositol anchors regulate glycosphingolipid levels. J. Lipid Res. 53, 1522\u20131534 (2012).","journal-title":"J. Lipid Res."},{"key":"BFnchembio1889_CR51","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/stke.2001.67.pl1","volume":"2001","author":"MC Sullards","year":"2001","unstructured":"Sullards, M.C. & Merrill, A.H. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci. STKE 2001, pl1 (2001).","journal-title":"Sci. STKE"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1889","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T16:09:06Z","timestamp":1650038946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.1889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFnchembio1889"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.1889","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,17]]},"assertion":[{"value":"22 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}